» Articles » PMID: 16237083

Respiratory Syncytial Virus Infection of Monocyte-derived Dendritic Cells Decreases Their Capacity to Activate CD4 T Cells

Overview
Journal J Immunol
Date 2005 Oct 21
PMID 16237083
Citations 61
Authors
Affiliations
Soon will be listed here.
Abstract

Respiratory syncytial virus (RSV) is a major cause of severe lower respiratory tract infections in children, the elderly, and immune-compromised individuals. CD4 and CD8 T cells play a crucial role in the elimination of RSV from the infected lung, but T cell memory is not sufficient to completely prevent reinfections. The nature of the adaptive immune response depends on innate immune reactions initiated after interaction of invading pathogens with host APCs. For respiratory pathogens myeloid dendritic cell (DC) precursors that are located underneath the epithelial cell layer lining the airways may play a crucial role in primary activation of T cells and regulating their functional potential. In this study, we investigated the role of human monocyte-derived DC in RSV infection. We showed that monocyte-derived DC can be productively infected, which results in maturation of the DC judged by the up-regulation of CD80, CD83, CD86, and HLA class II molecules. However, RSV infection of DC caused impaired CD4 T cell activation characterized by a lower T cell proliferation and ablation of cytokine production in activated T cells. The suppressive effect was caused by an as yet unidentified soluble factor produced by RSV-infected DC.

Citing Articles

The Role of the CX3CR1-CX3CL1 Axis in Respiratory Syncytial Virus Infection and the Triggered Immune Response.

Rivas-Fuentes S, Salgado-Aguayo A, Santos-Mendoza T, Sevilla-Reyes E Int J Mol Sci. 2024; 25(18).

PMID: 39337288 PMC: 11432029. DOI: 10.3390/ijms25189800.


The role of respiratory syncytial virus G protein in immune cell infection and pathogenesis.

Anderson J, Do L, van Kasteren P, Licciardi P EBioMedicine. 2024; 107:105318.

PMID: 39217853 PMC: 11402919. DOI: 10.1016/j.ebiom.2024.105318.


Host Responses to Respiratory Syncytial Virus Infection.

Agac A, Kolbe S, Ludlow M, Osterhaus A, Meineke R, Rimmelzwaan G Viruses. 2023; 15(10).

PMID: 37896776 PMC: 10611157. DOI: 10.3390/v15101999.


Molecular Profiling of Inflammatory Mediators in Human Respiratory Syncytial Virus and Human Bocavirus Infection.

Alkubaisi N, Aziz I, Alsaleh A, Alhetheel A, Almajhdi F Genes (Basel). 2023; 14(5).

PMID: 37239461 PMC: 10218554. DOI: 10.3390/genes14051101.


Immunity Cell Responses to RSV and the Role of Antiviral Inhibitors: A Systematic Review.

Churiso G, Husen G, Bulbula D, Abebe L Infect Drug Resist. 2022; 15:7413-7430.

PMID: 36540102 PMC: 9759992. DOI: 10.2147/IDR.S387479.